Safety Evaluation of Tarlatamab in SCLC: A Systematic Review and Meta-Analysis.

Vitale E, Maistrello L, Rizzo A, Galetta D, Longo V

DOI: 10.1016/j.jtocrr.2026.101010
Published: 2026 Sep
Container: JTO clinical and research reports
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.jtocrr.2026.101010,
  title = {Safety Evaluation of Tarlatamab in SCLC: A Systematic Review and Meta-Analysis.},
  author = {Vitale E and Maistrello L and Rizzo A and Galetta D and Longo V},
  year = {2026},
  journal = {JTO clinical and research reports},
  doi = {10.1016/j.jtocrr.2026.101010},
  url = {https://doi.org/10.1016/j.jtocrr.2026.101010}
}

RIS

TY  - JOUR
TI  - Safety Evaluation of Tarlatamab in SCLC: A Systematic Review and Meta-Analysis.
AU  - Vitale E
AU  - Maistrello L
AU  - Rizzo A
AU  - Galetta D
AU  - Longo V
PY  - 2026
JO  - JTO clinical and research reports
DO  - 10.1016/j.jtocrr.2026.101010
UR  - https://doi.org/10.1016/j.jtocrr.2026.101010
ER  -

APA

E, V., L, M., A, R., D, G., & V, L. (2026). Safety Evaluation of Tarlatamab in SCLC: A Systematic Review and Meta-Analysis.. JTO clinical and research reports. https://doi.org/10.1016/j.jtocrr.2026.101010

Source records

pubmed · retrieved 2026-09-26T01:48:07.904Z